Fiber-based chromatography to improve productivity in downstream AAV processing
sponsored by Cytiva
December 2, 2020 at 17:00 UK
Speaker: Dr. Peter Guterstam
Product Manager, Next Generation Resins and Technologies, Cytiva
As more AAV-based gene therapies move towards the clinic, there is a growing need for scalable and cost-effective production processes that maintain virus quality. In downstream processing, the capture chromatography step is a bottleneck. To address the need for higher productivity, we are developing a novel fiber technology, Fibro, which uses a proprietary structure that overcomes the diffusional and flow limitations of packed- bed chromatography. The fiber structure is highly open to facilitate mass transfer without diffusion, as with membrane and monolith technologies. Unlike those options, the Fibro structure provides a large surface area resulting from an additive manufacturing process.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine